Nalaganje...
Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?
Currently, four non-vitamin K antagonists oral anticoagulants (NOACs) are available for stroke prevention in atrial fibrillation (AF). These have been in clinical use for up to 10 years now. Besides data of the initial phase III clinical trials, now clinical data, several sub-studies, meta-analyses,...
Shranjeno v:
| izdano v: | Eur Heart J Suppl |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753780/ https://ncbi.nlm.nih.gov/pubmed/33380942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suaa177 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|